Delivery Order SPE2DB24D1104-SPE2DB25FYAR5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Bridion 200 mg/2 ml vials with a ceiling value of $13,804.03. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, was competitively awarded with no set-aside designation. Performance of the order is to be fulfilled...
- The Defense Logistics Agency awarded a $49,205.91 delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for the supply of Bridion 500 mg/5 mL vials. The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of October 9, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 29, 2025, for Bridion 500 mg/5 mL vials, with a ceiling value of $35,252.62 under firm fixed-price terms. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This competitively awarded, non-set-aside delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Bridion 200 mg/2 mL vials totaling $2,544.38 with a completion date of August 26, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure, with performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $60,425.21 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on August 27, 2025, with an ultimate completion date of August 28, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through open competition with no...
- The Defense Logistics Agency awarded a delivery order valued at $3,070.80 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive award utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $39,774.31 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Bridion 500 mg/5 mL vials. The contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support contract enabling...
- The Defense Logistics Agency awarded a $1,095.66 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price delivery order, which is expected to be completed by September 4, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $13,449.57 to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 21, 2025, for the supply of Bridion 200mg/2ml (10 units) with a ceiling value of $24,536.83. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by August 15, 2025. The contract represents a child order under AmerisourceBergen's larger...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYAR5Delivery Order
The Defense Logistics Agency awarded a $5,818.60 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Bridion 200 mg/2 mL vials. The contract, which is not set-aside and carries a firm fixed price, will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, with an ultimate completion date of May 7, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceuticals, specialty medications, vaccines, and medical supplies to support military healthcare programs worldwide. This delivery order for Bridion, a neuromuscular blocking agent reversal medication used in anesthesia, exemplifies the company's role in fulfilling specialized pharmaceutical needs across the Defense Health Agency and other federal healthcare systems through the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 5/6/25 |